Hanol Biopharma has newly appeared among the top searched stocks.


As of 12:30 PM on the 5th, Hanol Biopharma is trading at 35,100 KRW, up 4.78% from the previous day. This represents a 27.17% increase compared to October 30. Hanol Biopharma is known as an R&D-focused pharmaceutical and biotechnology company.

Today, foreigners have net purchased 33,998 shares of Hanol Biopharma, and institutions have net purchased 39,000 shares, according to provisional data. Over the past five days, individual investors have net sold 343,411 shares, while foreigners and institutions have net bought 63,049 shares and 282,302 shares, respectively.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing